TIGAR/C12orf5 Antibody Blocking Peptide

Product Discontinued

TIGAR/C12orf5 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 18 amino acids near the center of human TIGAR.

  Source: Synthetic

  (Accession #: NP_065108)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: TIGAR
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76765.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for TIGAR/C12orf5 Antibody Blocking Peptide

• C12orf5
• chromosome 12 open reading frame 5
• EC 3.1.3.46
• probable fructose-2,6-bisphosphatase TIGAR
• TIGAR
• TIGARTP53-induced glycolysis and apoptosis regulator
• transactivated by NS3TP2 protein

Background

The TIGAR gene is regulated as part of the p53 tumor suppressor pathway and encodes a protein with sequence similarity tothe bisphosphate domain of the glycolytic enzyme that degrades fructose-2,6-bisphosphate. The protein functions byblocking glycolysis and d

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: TIGAR